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http://dxObjective: Surgical site infection (SSI), particularly deep sternal wound infection (DSWI), is a serious
complication after cardiovascular surgery because of its high mortality rate. We evaluated the effectiveness
of an SSI bundle to reduce DSWI and identify the risk factors for DSWI.
Methods: During the period January 2004 to February 2012, 1374 consecutive patients undergoing cardiovas-
cular surgery via sternotomy were included. The cohort was separated into periods from January 2004 through
February 2007 (period I, 682 patients) and March 2007 through February 2012 (period II, 692 patients). During
period II, all preventive measures for DSWI were completed as an SSI bundle. We compared the DSWI rate
between the 2 periods. Univariate and multivariate analyses were performed for the entire period to identify
the risk factors for DSWI.
Results: DSWI occurred in 13 patients (1.9%) during period I and in 1 patient (0.14%) during period
II. The DSWI rate during period II was significantly decreased by 93%, compared with period I (P ¼ .001). In-
dependent risk factors forDSWI included obesity (odds ratio [OR], 3.4; 95% confidence interval [CI], 1.00-11.75;
P¼ .049), the use of 4 sternal wires (OR, 8.2; 95%CI, 1.39-48.14; P¼ .020), long operative time (OR, 4.4; 95%
CI, 1.20-16.23; P ¼ .026), and postoperative renal failure (OR, 9.0; 95% CI, 2.44-33.30; P ¼ .001).
Conclusions: Complete implementation of simple multidisciplinary prevention measures as a bundle can
greatly decrease the incidence of DSWI. (J Thorac Cardiovasc Surg 2014;148:2381-8)See related commentary on pages 2388-9.
P
MSurgical site infection (SSI), particularly deep sternal
wound infection (DSWI), is a serious complication after
cardiovascular surgery. Although the incidence of DSWI
is low, 0.13% to 4%,1-6 the mortality rate ranges from
7% to as high as 47%.4,7,8 DSWI also prolongs hospital
stays,6,7 increases costs,6,7 undermines patient and family
satisfaction,7 and discourages surgeons and nursing staff.
Because multiple factors contribute to DSWI, a multifac-
eted approach is essential to prevent it. Recently, implemen-
tation of evidence-based bundled interventions has
decreased the number of SSIs.9,10 To reduce DSWI, we
introduced and implemented a specific set of actions (ie,
bundle) of infection control measures. In this study, we
compared the DSWI rate before and after a bundle
introduction to evaluate the effectiveness of thishe Division of Cardiovascular Surgery, Ichinomiya Municipal Hospital,
omiya, Aichi, Japan.
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factors of DSWI.
METHODS
Study Design
This study is a retrospective, nonrandomized review of all patients who
underwent cardiovascular surgery via median sternotomy between January
2004 and February 2012 at our institution. A total of 1374 patients were re-
viewed. During the study period in October 2010, due to hospital merger
and acquisition, our team was transferred from Aichi Cardiovascular and
Respiratory Center to the hospital we are at now, which had not been per-
forming cardiovascular surgery. This hospital merger was approved by the
Japan Cardiovascular Surgery Database Organization and the 2 hospitals
were regarded as a serial institution. The institutional review board at
both hospitals approved the study.
The cohort was separated into periods from 2004 through February
2007 (period I, n ¼ 682) and March 2007 through February 2012
(period II, n ¼ 692). During period II, all preventive measures for
DSWI were completed as a SSI bundle consisting of 19 items, including
pre-, intra-, and postoperative infection control measures (Table 1). We
compared the DSWI rate between the 2 periods. Univariate and multi-
variate analyses were also performed for the entire period to identify
the DSWI risk factors. In our study, DSWI was defined according to
the guidelines of the Centers for Disease Control and Prevention
(CDC).11 SSIs are classified as being either incisional or organ/space.
Organ/space SSIs involve any part of the anatomy (eg, organ or space)
other than the surgical incision and at least 1 of the following: purulent
drainage, microorganisms, an abscess or other evidence of infection, or
diagnosis by a surgeon or attending physician. DSWI corresponds to an
organ/space SSI. Patients were followed for 1 year postoperatively. Due
to high rates of wound infection, patients with delayed sternal closure
have often been excluded from this type of study3; however, we
included these high-risk patients to verify the effectiveness of our
measures.diovascular Surgery c Volume 148, Number 5 2381
Abbreviations and Acronyms
BG ¼ blood glucose
CDC ¼ Centers for Disease Control and
Prevention
DSWI ¼ deep sternal wound infection
MRSA ¼ methicillin-resistant Staphylococcus
aureus
SSI ¼ surgical site infection
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MSurgical Management
Surgical techniques were standardized with no significant operative dif-
ferences between surgeons. The skin was incised with a scalpel and the pre-
sternal layers with electrocautery. After sternotomy, hemostasis was
achieved with bone wax and electrocautery. The thymus and pericardium
were incised using electrocautery. Postoperative hemostasis was achieved.
Silicone chest tubes (19F) were inserted. In addition, temporary epicardial
pacing wires were inserted. The sternumwas reapproximated with stainless
steel wires in a simple cerclage fashion. The number of wires used was
increased from 4 to 6 after 2006 for stronger sternal fixation. Abdominal
and presternal muscle layers were closed in a simple interrupted technique
using 0 coated, braided nylon nonabsorbable sutures. Subcutaneous tissue
and dermis were closed using 3-0 and 4-0 continuous absorbable monofil-
ament sutures, respectively.
Infection Control Measures
Patients undergoing elective surgery were screened for nasal carriage of
methicillin-resistant Staphylococcus aureus (MRSA) at the outpatient
clinic and if positive, mupirocin ointment was used for 3 days or more.
Patients were advised to shower or bathe with a plain soap (not an anti-
septic agent) on the day before the operative day if possible. Body hair was
removed, when necessary, using electric clippers after induction of anes-
thesia immediately preoperatively.
All operative sites were cleaned and disinfected with chlorhexidine-
alcohol solution (0.5% chlorhexidine gluconate in 77% ethanol solution)
with nonsterile gloves. This procedure was repeated 3 to 4 times as with a
lacquer coating, with the last coat applied using sterile gloves. Finally, 10%
povidone-iodine was applied to the skin using several pieces of cellulose
sponge. At least 2 minutes later, adhesive iodophor-impregnated plastic
incision drapes were applied to all surfaces of the operative field.
Surgical hand antisepsis was as follows: the 2-stage procedure or water-
less procedure was adopted according to staff preference. Afterward,
chlorhexidine-alcohol solution (0.2% chlorhexidine gluconate in 80%
ethanol solution) was applied.
All members of the operating team were wearing 2 pairs of gloves (ie,
double-gloving) during the operation and outer gloves were changed regu-
larly. Regardless of glove puncture, gloves were changed routinely after
such critical procedures as draping the patient, scratching the bone wax,
harvesting the graft, tying the suture of the prosthetic valve, and sternal
closure (scheduled glove change).
Cefazolin was used for antimicrobial prophylaxis against SSI. An initial
dose of 1 g was given within 30 minutes of the skin incision and the dose
was repeated for every 4 hours of additional surgical time. For MRSA car-
riers (1% of this series), 1 dose of 1 g vancomycin was added, which started
in the ward, was continued for 1 hour, and was completed within 1 hour
before skin incision. In all cases, prophylactic antibiotics were limited to
intraoperative use only.
Before sternal closure, the pericardial cavity and mediastinum were
washed with 1000 mL normal saline. After closing the sternal and abdom-
inal muscle layers, the wound was also washed with 500 mL normal saline
using a bulb syringe.2382 The Journal of Thoracic and Cardiovascular SurPostoperatively, the incision was covered for 2 days with a sterile gauze
under a larger elastic adhesive gauze. On the second postoperative day, the
gauze was exchanged for a transparent hydrocolloid dressing that was left
on for 5 days. On the seventh postoperative day, the dressing was removed
and the patient was permitted to shower or bathe. Aseptic or antibiotic
agents were not applied to the wound at any time. The wound was visually
inspected through the transparent dressing by a cardiovascular surgeon
daily.
Steroids have been used routinely for years. A single shot of 1500-mg
methylprednisolone was administered to patients before cardiopulmonary
bypass. However, since April 2006, the final year in period I, steroids
were not administered except in either hypothermic circulatory arrest sur-
gery or in patients who had received steroid therapy preoperatively.
Blood glucose (BG) was checked repeatedly intra- and postoperatively.
If the BG value was>140 mg/dL, continuous insulin therapy was initiated.
Postoperative BG levels were checked every 1 to 4 hours. Insulin infusion
was continued for at least 2 postoperative days or throughout the intensive
care unit stay. After discharge from the intensive care unit or when oral
feeding was initiated, intravenous insulin was transitioned to a sliding-
scale-guided intermittent subcutaneous insulin injection (target BG level,
<150 mg/dL), which was continued to at least the seventh postoperative
day.
After surgery, the fractional inspired concentration of oxygen was
increased to 100%. During at least the first 2 hours postoperatively, frac-
tional inspired concentration of oxygen was kept above 80% regardless
of the partial pressure of oxygen in arterial blood.
Statistical Analysis
Statistical analysis was performed using SPSS version 21.0 (IBM-SPSS
Inc, Armonk, NY). Data are expressed as means  standard deviation for
continuous variables and percentages for categorical variables. For com-
parison of continuous variables, Student t test or the Mann-Whitney U
test was used, depending on the normality of the data. Categorical variables
were compared using c2 or Fisher exact test. Univariate analysis and multi-
variate logistic regression analyses were used to determine risk predictors
of DSWI. The variables used for univariate analysis are listed in Table 2,
except the numbers of patients, wound infections, and deaths. The
threshold of the 75th percentile was used to categorize continuous
variables.
Variables with a P value< .05 by univariate analysis were included in
the final multivariable model.RESULTS
The clinical characteristics and surgical data of the period
I and period II cohorts are listed in Table 2. The patients dur-
ing period I were more likely to be obese and current
smokers, were more likely to have advanced symptoms
and to have had nonelective surgery, were more likely to
have undergone coronary artery bypass grafting, were less
likely to have hyperlipidemia, and were less likely to have
a family history of peripheral vascular disease or aortic sur-
gery than those in the period II cohort. The average duration
of operation, cardiopulmonary bypass, and aortic cross-
clamp timewere all significantly shorter in period I patients.
The incidence of intraoperative steroid use was higher in
period I patients. Most patients in period I received 4 sternal
wires, whereas 5 or 6 wires were used in period II patients.
During period II, no patient had shaved the previous day and
all patients received 80% oxygen. Patients in period I
required a longer intensive care unit stay. The hospitalgery c November 2014
TABLE 1. Specific actions (bundles) implemented to reduce/eliminate
surgical site infection
Preoperative
Nasal screening for MRSA
Intranasal mupirocin ointment for MRSA carriers
Intraoperative
Hair clipping immediately before the operation, if necessary
Surgical hand antisepsis: hand rubbing with 0.2% chlorhexidine-alcohol
solution
Patient skin preparation: 0.5% chlorhexidine-alcohol solution applied
repeatedly 3 to 4 times, as with a lacquer coating, with the last coat
applied using sterile gloves. Finally, 10% povidone-iodine applied to
the skin using several pieces of cellulose sponge.
Adhesive iodophor-impregnated plastic incise drapes applied to all
surfaces of the operative field
Administration of prophylactic antibiotics (1 g CEZ) 30 min before the
skin is incised
Readministration of prophylactic antibiotics (1 g CEZ) every 4 h
Discontinuation of prophylactic antibiotics during surgery
(intraoperatively only)
Ensure double-gloving for all surgical team members
Scheduled glove change after draping the patient, scratching the bone
wax, harvesting the graft, tying the suture of the prosthetic valve, and
sternal closure
Check blood glucose levels; if>140 mg/dL, start insulin infusion
No use of intraoperative steroids, with the exception of aortic surgery
with circulatory arrest
Irrigate pericardial cavity, sternum, and wound with saline
Sternal closure using at least 6 stainless steel wires
Postoperative
Maintain control of serum blood glucose levels<140 mg/dL
Administer 80% inspired oxygen for 2 h
Leave wound primarily covered with gauze occlusive dressing for 2 d
Protect wound with transparent hydrocolloid dressing for the next 5 d
MRSA, Methicillin-resistant Staphylococcus aureus; CEZ, cefazolin.
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Mmortality rate was similar between the 2 cohorts. DSWI
occurred in 13 patients in period I but only in 1 patient in
period II. The incidence rate significantly (93%) decreased
from 1.9% to 0.14% compared with period I (P ¼ .001).
Table 3 summarizes patient characteristics and surgical
data for those with DSWI and compares them with data
for patients without DSWI. The preoperative patients with
DSWI were more likely to be obese, and were more likely
to have advanced symptoms, to have had aortic surgery, or
to have been shaved the previous day. The average duration
of operative and cardiopulmonary bypass were significantly
longer in DSWI patients. Theywere alsomore likely to have
received 4 sternal wires and to have postoperative renal fail-
ure, including requiring hemodialysis. The requirement for
delayed closure was higher in DSWI patients and they also
required longer ventilation support and intensive care unit
stay than those without DSWI. The hospital mortality was
8-fold higher in DSWI patients (P ¼ .001).
Univariate analysis found statistical significance in
thoracic aortic surgery, obesity, New York HeartThe Journal of Thoracic and CarAssociation functional class III or IV, hair removal the pre-
vious day, sternal closure with 4 wires, long operative time,
delayed sternal closure, prolonged ventilation, and postop-
erative renal failure. Obesity, sternal closure with 4 wires,
long operative time, and postoperative renal failure were
identified as independent factors using multiple logistic
regressions (Table 4).
DISCUSSION
Although lower rates have been reported recently, the
mortality associated with DSWI has not changed for 15
years and it remains a lethal complication.3 According to
the Japan Adult Cardiovascular Surgery Database, which
includes 73,700 cases from 2004 to 2009, the incidence of
DSWI is 1.8%, with a mortality of 25.8%.4 In Japan,
DSWI prolongs hospital stay 4-fold and increases costs
nearly 6-fold.
Excellent surgical technique is widely believed to reduce
the risk of SSI.11 Such techniques include gentle handling
of tissues and maintaining effective hemostasis. Limited
use of electrocautery and pinpoint hemostasis for the pre-
sternal soft tissues are important to maintain tissue
viability.1
Nasal carriage of S. aureus increases the risk of SSI in
cardiac surgery.11 The Society of Thoracic Surgeons prac-
tice guidelines series6 recommends routine mupirocin
administration for all patients in the absence of a docu-
mented negative testing for Staphylococcal colonization.
This is necessary given the high mortality rates associated
with poststernotomy infections caused by S. aureus.6 A
recent meta-analysis9 revealed that nasal decolonization
and glycopeptide prophylaxis is effective for preventing
SSI caused by gram-positive bacteria after cardiac or ortho-
pedic surgery. Mupirocin is highly effective in eradicating
nasal S. aureus. However, because S. aureus strains can
become resistant to mupirocin, restricting its use is recom-
mended. We believe that mupirocin should be used only for
MRSA carriers.
Avoiding hair removal is the best way to prevent SSI.11 If
needed, clipping the morning of the operation has demon-
strated lower infection rates.11 We have performed clipping
after intubation, which is often preferable to avoid embar-
rassing a patient.
Because the skin is a major source of pathogens that cause
SSI, optimization of preoperative skin antisepsis may
decrease postoperative infections. Preoperative showering
or bathing with antiseptic products is controversial.11,12
Regarding cleansing of a patient’s skin in the operating
room, a recent study demonstrated that chlorhexidine-
alcohol is superior to povidone-iodine for preventing SSI.13
The superiority of chlorhexidine-alcohol is probably related
to its more rapid action, persistent activity despite exposure
to bodily fluids, and residual effect.13 Updated CDC guide-
lines14 describe that the greatest reduction in microbes atdiovascular Surgery c Volume 148, Number 5 2383
TABLE 2. Clinical characteristics and surgical data of the period I and period II cohorts
Variable Period I (January 2004-February 2007) Period II (March 2007-February 2012) P value
No. of patients 682 692
Age, y 66.0  10.2 68.2  10.1 <.001
Male sex 456 (66.9) 458 (66.2) .819
Family history 36 (5.3) 83 (12.0) <.001
Obesity 130 (19.1) 103 (14.9) .044
Hypertension 421 (61.7) 434 (62.7) .739
Diabetes mellitus 233 (34.2) 216 (31.2) .250
Hyperlipidemia 232 (34.0) 280 (40.5) .014
Preoperative brain damage 68 (10.0) 59 (8.5) .402
COPD 7 (1.0) 16 (2.3) .091
Peripheral vascular disease 18 (2.6) 95 (13.7) <.001
Smoking 348 (51.0) 392 (56.7) .040
Current smoking 189 (27.7) 143 (20.7) .002
Preoperative steroid use 9 (1.3) 8 (1.2) .812
IABP 123 (18.0) 100 (14.5) .079
NYHA functional class III-IV 324 (47.5) 219 (31.7) <.001
Preoperative serum creatinine, mg/dL 1.13  1.28 1.04  0.88 .227
Preoperative renal failure 36 (5.3) 32 (4.6) .620
Preoperative renal failure requiring HD 10 (1.5) 16 (2.3) .323
IE 8 (1.2) 11 (1.6) .645
Nonelective 231 (33.9) 177 (25.6) .001
Redo 26 (3.8) 37 (5.4) .198
Category
CABG 378 (55.4) 289 (41.8) <.001
Valve 190 (27.9) 283 (40.9) <.001
Aorta 64 (9.4) 93 (13.4) .022
Congenital 24 (3.5) 8 (1.2) .004
Other 26 (3.8) 19 (2.8) .291
Hair removal previous day 221 (32.4) 0 (0.0) .000
Intraoperative steroid use 539 (79.0) 103 (14.9) <.001
Used sternal wires
4 628 (92.1) 0 (0.0) .000
5 37 (5.4) 102 (14.7) <.001
6 17 (2.5) 590 (85.3) <.001
Operative time, min 358  116 409  145 <.001
Arrest time, min 114  44 154  61 <.001
CPB time, min 185  83 231  107 <.001
Postoperative 80% oxygen supply 424 (62.2) 692 (100) <.001
Postoperative stroke 19 (2.8) 25 (3.6) .445
Postoperative serum creatinine, mg/dL 1.47  1.57 1.45  1.37 .641
Postoperative renal failure 30 (4.4) 31 (4.5) .942
Postoperative HD 16 (2.3) 19 (2.8) .733
Blood transfusion 527 (77.3) 554 (80.1) .211
Early reoperation for bleeding 35 (5.1) 24 (3.5) .144
Delayed sternal closure 2 (0.3) 9 (1.3) .064
Prolonged ventilation (>24 h) 233 (34.2) 227 (32.8) .607
ICU stay, d 4.2  4.2 3.7  4.4 <.001
Deep sternal wound infection 13 (1.9) 1 (0.14) .001
Hospital death 29 (4.3) 23 (3.3) .398
Continuous data are presented as mean  standard deviation. Categorical data are presented as the number of patients (%) in each category. COPD, Chronic obstructive
pulmonary disease; IABP, intra-aortic balloon pump (preoperative); NYHA, New York Heart Association; HD, hemodialysis; IE, infectious endocarditis; CPB, cardiopulmonary
bypass; ICU, intensive care unit; CABG, coronary artery bypass grafting.
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Mthe operative site seems to occur with use of chlorhexidine/
alcohol-based products or an iodine povacrylex/alcohol. In
the prevention of microbial colonization in central venous2384 The Journal of Thoracic and Cardiovascular Surcatheters, combined skin disinfection with propanol/chlor-
hexidine followed by povidone-iodine has demonstrated
superiority compared with either regimen alone.15 We havegery c November 2014
TABLE 3. Characteristics and surgical data for patients with deep
sternal wound infection (DSWI) and without DSWI
Variable No DSWI DSWI P value
No. of patients 1360 14
Age, y 67.1  10.2 68.3  7.5 .657
Male sex 904 (66.5) 10 (71.4) .784
Family history 118 (8.7) 1 (7.1) 1.000
Obesity 227 (16.7) 6 (42.9) .020
Hypertension 845 (62.1) 10 (71.4) .587
Diabetes mellitus 443 (32.6) 6 (42.9) .404
Hyperlipidemia 505 (37.1) 7 (50.0) .406
Preoperative brain damage 125 (9.2) 2 (14.3) .376
COPD 22 (1.6) 1 (7.1) .211
Peripheral vascular disease 14 (1.0) 0 (0) .621
Smoking 731 (53.6) 9 (64.3) .592
Current smoking 327 (24.0) 5 (35.7) .346
Preoperative steroid use 17 (1.3) 0 (0) 1.000
IABP 219 (16.1) 4 (28.6) .263
NYHA functional class III-IV 532 (39.1) 11 (78.6) .004
Preoperative serum creatinine, mg/dL 1.08  1.10 1.09  0.62 .995
Preoperative renal failure 67 (4.9) 1 (7.1) .510
Preoperative renal failure requiring HD 25 (1.8) 1 (7.1) .236
IE 18 (1.3) 1 (7.1) .178
Nonelective 402 (29.6) 6 (42.9) .376
Redo 63 (4.6) 0 (0.0) 1.000
Category
CABG 661 (48.6) 6 (42.9) .791
Valve 471 (34.6) 2 (14.3) .158
Aorta 151 (11.1) 6 (42.9) .003
Congenital 32 (2.4) 0 (0.0) 1.000
Other 45 (3.3) 0 (0.0) 1.000
Hair removal previous day 215 (15.8) 6 (42.9) .016
Intraoperative steroid use 632 (46.5) 10 (71.4) .103
Used sternal wires
4 616 (45.3) 12 (85.7) .003
5 138 (10.2) 1 (7.1) 1.000
6 606 (44.6) 1 (7.1) .005
Operative time, min 383  132 488  216 .004
Arrest time, min 134  57 132  57 .907
CPB time, min 207  98 257  157 .059
Oxygen 1107 (81.4) 9 (64.3) .157
Postoperative stroke 42 (3.1) 2 (14.3) .071
Postoperative serum creatinine, mg/dL 1.45  1.46 2.90  2.13 .024
Postoperative renal failure 54 (4.0) 7 (50.0) <.001
Postoperative HD 30 (2.2) 5 (35.7) <.001
Blood transfusion 1070 (78.7) 11 (78.6) 1.000
Early reoperation for bleeding 57 (4.2) 2 (14.3) .119
Delayed sternal closure 9 (0.7) 2 (14.3) .005
Prolonged ventilation (>24 h) 448 (32.9) 12 (85.7) <.001
ICU stay, d 3.9  4.2 12.4  10.3 .008
Hospital stay, d 26.4  20.4 96.4  74.3 <.001
Hospital death 48 (3.5) 4 (28.6) .001
Continuous data are presented as mean  standard deviation. Categorical data are
presented as the number of patients (%) in each category.COPD, Chronic obstructive
pulmonary disease; IABP, intra-aortic balloon pump (preoperative);NYHA, NewYork
Heart Association; HD, hemodialysis; IE, infectious endocarditis; CPB, cardiopul-
monary bypass; ICU, intensive care unit; DSWI, deep sternal wound infection;
CABG, coronary artery bypass grafting.
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Mbeen performing this combined method. Chlorhexidine-
alcohol is also recommended for decontaminationof surgical
team members’ hands.14The Journal of Thoracic and CarRarely, surgical gloves have pinholes even directly out of
the package. According to Japanese industrial standards,
pinhole defects are expected in up to 3 of 80 gloves in Japan.
This incidence is nonnegligible. Double-gloving signifi-
cantly reduces the number of perforations16 and may reduce
the risk of wound contamination from staff members
through pinhole or accidental punctures in surgical
gloves.11 Updated CDC recommendations14 request that
all members of operative teams double-glove and to change
gloves when any perforation is identified. Moreover, our
scheduled glove change greatly minimizes the risk of con-
tact between a surgeon’s hand and a surgical site.
The optimal duration of prophylaxis has been debated.
Many investigators believe that longer durations are
needed.17 However, the continuation of prophylaxis until
all catheters and drains have been removed is not appro-
priate.17 CDC guidelines11 recommend that therapeutic
levels of antimicrobial prophylaxis be maintained until, at
most, a few hours until after an incision is closed. The So-
ciety of Thoracic Surgeons recommends 48 hours or less,7
based on a study by Harbarth and colleagues. The duration
of their study unfortunately depended on the surgeon’s pref-
erences, introducing considerable bias. Recently, Mertz and
colleagues18 used a systematic review and meta-analysis to
conclude that longer-term prophylaxis (ie, 24 hours)
reduced sternal and DSWIs when compared with short-
term antibiotic prophylaxis (ie,<24 hours); however, they
also commented on the heterogeneity of antibiotic regimens
and the risk of bias in the published studies. Actually, in
their review, cefazolin was used in only 3 of 12 studies,
and the regimens varied. Many studies demonstrate that a
single dose or within-24-hours dose is sufficient to opti-
mally reduce SSI.19 Prolonged administration of antibiotics
carries increased costs, the prospect of drug toxicity, and
the development of resistant bacterial strains.7,17 We
believe antibiotic prophylaxis given intraoperatively only
effectively minimizes infectious complications, as
recommended by the CDC.11
Wound irrigation is expected to reduce the contaminating
microorganisms to below the level required to produce
infection. The best solution for irrigation is normal saline.
It is safe, cheap, and readily available and does not impair
the healing process.20 The addition of an antiseptic to the
irrigating solution can increase the risk of infection by lead-
ing to tissue necrosis.20
Moist wound healing is an essential concept. Occlusive
dressings, especially hydrocolloid dressings, have demon-
strated lower infection rates compared with conventional
gauze dressings.21 Originally, hydrocolloid dressings were
applied immediately after closing an incision. However,
we used gauze occlusive dressings first to handle the excess
exudate bleeding, and then changed to hydrocolloid dress-
ings. This procedure of delayed hydrocolloid dressings
may be controversial. According to CDC guidelines,11diovascular Surgery c Volume 148, Number 5 2385
TABLE 4. Univariate and multivariate analysis results for deep sternal wound infection
Characteristic
Univariate analysis Multivariate analysis
OR 95% CI P value OR 95% CI P value
Aorta 6.005 2.056-17.541 .001
Obesity 3.743 1.289-10.892 .015 3.433 1.003-11.750 .049
NYHA functional class III-IV 5.707 1.585-20.551 .008
Hair removal previous day 3.994 1.372-11.627 .011
Use of 4 sternal wires 7.247 1.616-32.502 .010 8.169 1.386-48.141 .020
Long operative time 4.063 1.400-11.795 .010 4.411 1.199-16.229 .026
Delayed sternal closure 25.019 4.881-128.225 <.001
Prolonged ventilation 12.214 2.722-54.807 .001
Postoperative renal failure 24.185 8.193-71.390 <.001 9.005 2.435-33.304 .001
OR, Odds ratio; CI, confidence interval; NYHA, New York Heart Association.
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Mbeyond 48 hours it is unclear if an incision closed primarily
must be covered by a dressing. Is also unclear if showering
or bathing is detrimental to healing.11 Antiseptic agents
should not be applied to an incision because they have dele-
terious effects on the many cells that influence wound
healing.20
Steroids use in cardiovascular surgery remains controver-
sial.22,23 Steroids have been routinely used for years in a
considerable number of institutions during cardiac surgery
with cardiopulmonary bypass. Although steroid therapy is
expected to reduce the systemic inflammatory response to
cardiopulmonary bypass, the clinical benefit is unclear.
Furthermore, steroids may in fact be detrimental with
risks including hyperglycemia, impaired wound healing,
and increased risk of infection.23 Recently, a well-
designed randomized controlled trial24 revealed that intrao-
perative high-dose dexamethasone in adults undergoing
cardiac surgery did not reduce the 30-day incidence of ma-
jor adverse events compared with placebo. The effect of
high-dose methylprednisolone for cardiac surgery is being
evaluated in a large, ongoing study (the Steroids in Cardiac
Surgery trial).24 Although we have ceased routine adminis-
tration of high-dose methylprednisolone, no clinical
adverse effects have been shown. If steroids are essential
for hypothermic surgery remains an unanswered dilemma.
Perioperative BG control is important to prevent SSI.
Maintaining BG levels 200 mg/dL using continuous,
intravenous insulin infusion has been shown to significantly
reduce the incidence of SSI.25 In cardiac surgery, target BG
levels <150 mg/dL are important.26 Lipshutz and col-
leagues27 concluded in an evidence-based review that main-
taining BG levels<150 mg/dL and reducing BG variability
in the perioperative period may be both safe and effective.
Intensive insulin therapy (target BG, 80-110 mg/dL) has
been controversial and the effect on SSIs has not been
demonstrated.28 In consideration of the risk and benefit,
we adopted Krinsley’s protocol,29 which maintains a
BG<140mg/dL. Intraoperative BG control in cardiovascu-
lar surgery has also been recognized to decrease DSWI.27
During both the intra- and postoperative periods2386 The Journal of Thoracic and Cardiovascular Surhypoglycemia can be avoided by careful management,
including BG sampling at 30- to 60-minute intervals if
necessary.
Oxidative killing of pathogens by polymorphonuclear
leukocytes is the primary mechanism of defense against sur-
gical pathogens.30 Several randomized controlled trials31,32
have been conducted to assess the effect of perioperative
supplemental oxygen administration in reducing the
incidence of SSI. However, the results conflicted31,32 and
results of even meta-analyses can differ according to which
trials are included.14,33 For adult cardiac surgery,
Bustamante and colleagues34 concluded that supplemental
inspired oxygen does not appear to be clinically useful.
Although the effect remains controversial, we recommend
this therapy because its cost and associated risks are trivial.
Recently updated CDC guidelines14 suggest that hyperoxia
may be beneficial in various types of surgery.
Many risk factors for DSWI have been proposed; howev-
er, risk factors have differed between institutions or studies
and are occasionally conflicted. Obesity is a common risk
factor for DSWI,5 whereas diabetes mellitus and reopera-
tion for bleeding were not significant risk factors in our
study. The use of only 4 sternal wires is a significant risk
factor, which highlights the importance of sternal stability.2
Sternal instability is itself strongly associated with DSWI,2
and it is likely that DSWI often develops from a minor skin
or subcutaneous infection in the sternal wound and that the
infection may spread inward to the mediastinal space if ster-
nal dehiscence occurs.2 Tight, secure approximation of the
sternum with sufficient sutures will most likely help to
reduce infection.35 Aggressive antitussive use should be
considered2 because coughing causes shear stress at the
sternal wires and the hemisternal junction. Stress along ster-
nal wires causes cutting of wires and bony fractures.3
During the late 1990s, evidence-based medicine was pro-
pounded in Japan. In the area of infection control, CDC
guidelines11 have been recognized as the global standard.
However, not all measures to prevent SSI are clearly vali-
dated. Some of the routinely used infection control prac-
tices cannot be investigated rigorously due to ethical orgery c November 2014
Miyahara et al Perioperative Managementlogistic reasons.11 Some recommendations are unproved,
controversial, or revised by later studies. Various factors
are related to infection and it may be difficult to demon-
strate if 1 preventive measure is effective on the basis that
other factors, including patient status, are equal. Also, the
findings from a specific kind of surgery may not be appli-
cable to cardiovascular surgery. Although individual inter-
ventions may not directly affect the rate of SSI,
implementation of multiple strategies as bundled interven-
tions can reduce the incidence of infection.10 We must
choose certain measures to put into practice while consid-
ering cost-effectiveness, health insurance systems, and
manpower. The key to reducing SSI is the complete imple-
mentation of simple, multidisciplinary prevention measures
in the pre-, intra-, and postoperative periods. A checklist
may help to achieve compliance.14 DSWI can potentially
be almost eliminated by prevention efforts.Study Limitations
Our study has several limitations. First, this study
involved a clinical review of patients and a historical differ-
ence existed between the 2 groups. Due to the nonrandom-
ized observational design of the study, there were some
significant differences in preoperative characteristics. Sec-
ond, the number of patients was smaller than in previous
studies.1-5,8 Finally, the small number of patients with
DSWI in each period is the principle limitation of this
study.5 The low incidence of DSWI limited the statistical
modeling efforts to identify multivariate predictors of
DSWI.CONCLUSIONS
Complete implementation of simple multidisciplinary
prevention measures can result in a very low incidence of
DSWI.P
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of cardiac surgery with deep sternal wound infection
(eg, mediastinitis) being the most feared. The good news
is that the prevalence is low, around 0.5% to 5%; the bad
news is that the associated mortality may be high, around
40%. The financial cost must also be considered; the attrib-
utable cost for a procedure complicated by deep sternal
wound infection may be as much as 3 times greater than
that of an uncomplicated procedure. It is no longer accept-
able to view surgical site infection as a possible risk and
unfortunate outcome of a surgical procedure, especially
because implementation of effective infection prevention
programs, such as those presented here, may significantly
reduce the occurrence of infection.1,2
In this article of the Journal of Thoracic and Cardiovascu-
lar Surgery, Miyahara and colleagues2 report a significant
reduction in the prevalence of deep sternal wound infection
after the implementation of a specific set of simple multidis-
ciplinary prevention measures (the bundle).2 The success
of the bundle lies in that it recognizes that multiple
factors contribute to deep sternal wound infection and that
multiple modalities of treatment are essential to prevent it.
The factors that contribute to infection and the modalities of
treatment may be collected into 2 simple and convenient as-
semblages: patient characteristics and operative issues.3In cardiac surgery, patient characteristics possibly associ-
ated with an increased risk of surgical site infection include
coincident remote site bacterial colonization, diabetes, sys-
temic steroid use, obesity, and the extremes of age. The
most modifiable of these risk factors is that of coincident
preoperative nares colonization with Staphylococcus
aureus. Such carriage is a powerful independent risk factor
for surgical site infection after cardiac operations. Mupiro-
cin ointment is an effective topical agent against this hazard,
and treatment is indicated for all patients. Current
consensus is that broad use of the antibiotic is unlikely to
result in mupirocin resistance because treatment courses
are brief.3
Operative issues may be further categorized into inter-
ventions that occur during specific periods: intraoperative
and postoperative. The intraoperative infection control
measures recommended by the Centers for Disease Control
and Prevention include hair clipping immediately before the
operation, antimicrobial prophylaxis in accordance with
evidence-based standards and guidelines, and use of appro-
priate antiseptic agents and techniques for skin prepara-
tion.3 Miyahara and colleagues2 add to the list additional
maneuvers that include the use of an iodophor-
impregnated drape, double-gloving for all surgical team
members, scheduled glove changes, minimization of intra-
operative steroids, pericardial irrigation, and secure sternal
closure with at least 6 wires.
Best practices of postoperative infection control include
measures nicely outlined by the Centers for Disease Control
andPrevention3 andMiyahara and colleagues.2These include
the restoration of normothermia, maintenance of control of
serum blood glucose levels at less than 140 mg/dL, adminis-
tration of greater than 80% inspired oxygen for 2 hours,
continuation of antibiotics according to evidence-based stan-
dards and guidelines, and wound coverage with a sterile, dry
dressing for at least 48 hours.2,3 Miyahara and colleagues2 go
further to recommend changing thewounddressing to a trans-
parent hydrocolloid dressing for the next 5 days.gery c November 2014
